National (Australia) HPV 3 dose vaccination coverage for males turning 15 years of age in 2014

State Estimated
Resident
Population
(as at
30/06/2014)		 Coverage Dose 1 Coverage Dose 2 Coverage Dose 3 Total
Doses
n % n % n %
ACT 2,205 1,798 81.5% 1,709 77.5% 1,425 64.6% 4,932
NSW 46,137 32,570 70.6% 31,163 67.5% 26,585 57.6% 90,318
NT 1,609 1,305 81.1% 1,209 75.1% 1,042 64.8% 3,556
QLD 30,568 22,307 73.0% 21,229 69.4% 19,071 62.4% 62,607
SA 10,333 7,840 75.9% 7,517 72.7% 6,639 64.3% 21,996
TAS 3,378 2,457 72.7% 2,306 68.3% 1,966 58.2% 6,729
VIC 35,302 27,590 78.2% 26,367 74.7% 23,940 67.8% 77,897
WA 15,905 11,432 71.9% 10,941 68.8% 10,035 63.1% 32,408
NAT 145,437 107,299 73.8% 102,441 70.4% 90,703 62.4% 300,443


NOTES

  • Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 04 JULY 2018 and includes males vaccinated between APR 2007 and JUN 2018.
  • Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
  • Population is Estimated Resident Population 2014 (as at 30/6/2014) from the Australian Bureau of Statistics - CAT 3101.0 Australian Demographics Statistics, Tables 51 to 58: Estimated Resident Population by Single Year of Age by State and Territory, FINAL based on 2016 census data published JUN 2018. 
  • Age is age as at date of ERP estimate (30th June).
  • Coverage is calculated as doses administered and reported to the HPV Register/Estimated Resident Population expressed as a percentage.
  • Excludes consumers who do not wish their details to be recorded on the HPV Register.
  • The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
  • As the ages of students in the first year of high school varies between jurisdictions, age 15 is used as the age for routine review of vaccination coverage that provides the best comparison to allow for these varying ages in administration, as per World Health Organization (WHO) recommendations. These are the first national estimates for coverage in males at age 15 and reflect vaccination during the male catch-up program 2013-2014 rather than routine vaccination of males in the first year of high school. 
  • HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.